News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Nussbaum Ran
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 02/28/2023 |
4/A
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 02/28/2023 |
4/A
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 32,723 options to buy
@ $5.94, valued at
$194.4k
Exercised 15,276 options to buy
@ $5.94, valued at
$90.7k
|
|
| 02/28/2023 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 2,211 options to buy
@ $5, valued at
$11.1k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 10/25/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 32,723 options to buy
@ $5.94, valued at
$194.4k
Exercised 15,276 options to buy
@ $5.94, valued at
$90.7k
|
|
| 08/25/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 6,817 options to buy
@ $7.06, valued at
$48.1k
Granted 3,183 options to buy
@ $7.06, valued at
$22.5k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Nussbaum Ran reports a 5% stake in PIERIS PHARMACEUTICALS, INC. |
| 06/09/2021 |
4/A
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 06/09/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 2,211 options to buy
@ $5, valued at
$11.1k
Granted 6,817 options to buy
@ $17.89, valued at
$122k
Granted 3,183 options to buy
@ $17.89, valued at
$56.9k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 1,576,881 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 11/19/2020 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Bought 26,634 shares
@ $50, valued at
$1.3M
Bought 12,966 shares
@ $50, valued at
$648.3k
Bought 14,400 shares
@ $50, valued at
$720k
Bought 6,000 shares
@ $50, valued at
$300k
|
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 05/22/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
|
|
| 04/13/2020 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Converted 1,363,542 shares
@ $0
Converted 663,825 shares
@ $0
Converted 737,226 shares
@ $0
Converted 169,307 shares
@ $0
Converted 82,425 shares
@ $0
Converted 91,538 shares
@ $0
Converted 68,654 shares
@ $0
Converted 163,612 shares
@ $0
Converted 88,460 shares
@ $0
Converted 79,653 shares
@ $0
Converted 36,858 shares
@ $0 |
|
| 04/07/2020 |
3
| Nussbaum Ran (10% Owner) has filed a Form 3 on Keros Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Nussbaum Ran reports a 7.7% stake in LogicBio Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|